Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DVL1 |
| Upstream (Parents) |
|---|
| (<<) AKT3 → DVL1 |
| (<<) BBS1 → DVL1 |
| (<<) EPHB4 → DVL1 |
| (<<) ITPR1 → DVL1 |
| (<<) LYPLA2 → DVL1 |
| (<<) MAP1B → DVL1 |
| (<<) PRKCZ → DVL1 |
| (<<) TCOF1 → DVL1 |
| (<<) TK2 → DVL1 |
| Downstream (Children) |
|---|
| DVL1 → BMPR2 (>>) |
| DVL1 → EIF4EBP1 (>>) |
| DVL1 → GLTPD1 (>>) |
| DVL1 → HLA-DOA (>>) |
| DVL1 → IL1F7 (>>) |
| DVL1 → KRT75 (>>) |
| DVL1 → PHOX2A (>>) |
| DVL1 → PRKACB (>>) |
| DVL1 → RRP1 (>>) |
| DVL1 → RXRG (>>) |
| DVL1 → WNT7B (>>) |
| DVL1 → YRDC (>>) |
